How Clinical Trial Data Have Shaped Amivantamab Use in Practice for EGFR-Mutated NSCLC | OncLive
How Clinical Trial Data Have Shaped Amivantamab Use in Practice for …
1 month ago
onclive.com
The Role of Amivantamab Plus Lazertinib in EGFR-Mutated NSCLC Management | OncLive
The Role of Amivantamab Plus Lazertinib in EGFR-Mutated NSCL…
1 month ago
onclive.com
Amivantamab Toxicity Mitigation Strategies in the Treatment of EGFR-Mutant NSCLC | OncLive
Amivantamab Toxicity Mitigation Strategies in the Treatment of EGF…
Apr 7, 2025
onclive.com
Amivantamab Plus Chemotherapy vs Chemotherapy as First-line Treatment in EGFR Exon 20 Insertion–Mutated Advanced NSCLC: Primary Results From PAPILLON, a Randomized Phase 3 Global Study | OncLive
13:44
Amivantamab Plus Chemotherapy vs Chemotherapy as First-line Tre…
Nov 30, 2023
onclive.com
Subcutaneous Amivantamab Reshapes Frontline EGFR-Mutant NSCLC Care
5:12
Subcutaneous Amivantamab Reshapes Frontline EGFR-Mutant …
589 views1 month ago
YouTubeOncUpdates: Latest Oncology Insights
The Role of Amivantamab Plus Lazertinib in EGFR NSCLC | OncLive
The Role of Amivantamab Plus Lazertinib in EGFR NSCLC | OncLive
2 months ago
onclive.com
Amivantamab Lazertinib in EGFR-Mutated Advanced NSCLC: Results from MARIPOSA | Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
6:53
Amivantamab Lazertinib in EGFR-Mutated Advanced NSCLC: Result…
Nov 14, 2023
targetedonc.com
Treatment Options for EGFRm NSCLC: Amivantamab Lazertinib
130 viewsFeb 21, 2025
vumedi.com
Dr Leighl on Amivantamab in Advanced NSCLC With MET Exon …
Sep 12, 2023
onclive.com
Dr Girard on the Efficacy of First-Line Amivantamab Plus Chemothe…
Oct 21, 2023
onclive.com
ASCO® 2024 Insights: "PALOMA-2 Study - Subcutaneous Amivantam…
140 viewsJun 11, 2024
vumedi.com
PAPILLON Study - Amivantamab Chemo vs. Chemo as 1L Treatmen…
Feb 12, 2024
vumedi.com
Dr Sabari on the FDA Approval of Subcutaneous Amivantamab for E…
3 months ago
onclive.com
1:36
CHRYSALIS: Amivantamab for EGFR exon 20 insertion mutant N…
2.5K viewsFeb 26, 2021
YouTubeVJOncology
1:14
Predictive Biomarkers for Treatment With Amivantamab Plus Lazertini…
Apr 29, 2024
onclive.com
1:02
Dr Reckamp on Amivantamab in EGFR Exon 20–Mutated NSCLC
410 viewsJul 27, 2024
YouTubeOncLive
8:58
Subcutaneous Amivantamab vs Intravenous Amivantamab, Both i…
Jun 25, 2024
onclive.com
2021 ASCO Review on EGFR Resistance Strategies in NSCLC: …
275 viewsNov 21, 2021
vumedi.com
3:22
Amivantamab in NSCLC: Interpreting MARIPOSA and Guide…
3 months ago
pharmacytimes.com
Optimizing Patient Selection and Treatment Management with Amiv…
Feb 19, 2025
onclive.com
Amivantamab Plus Lazertinib vs Osimertinib in First-Line EGFR-Mu…
Jun 19, 2024
onclive.com
Subcutaneous Amivantamab for EGFR mNSCLC
Mar 14, 2025
vumedi.com
5:18
Expert video report on amivantamab in combination therapy for 1L trea…
2.4K viewsOct 30, 2023
YouTubeEuropean Society for Medical Oncology (ESMO)
Novel Mechanisms Set FDA-Approved Amivantamab-Lazertini…
Aug 30, 2024
ajmc.com
3:27
PALOMA-3: subcutaneous vs intravenous amivantamab + lazerti…
631 viewsJun 1, 2024
YouTubeVJOncology
2:07
PAPILLON: amivantamab plus chemotherapy in NSCLC with EGF…
421 viewsMay 13, 2024
YouTubeVJOncology
3:50
Amivantamab plus lazertinib is a new standard for EGFR-mutant NS…
976 viewsOct 11, 2024
YouTubeVJOncology
0:55
MARIPOSA Update - Amivantamab + Lazertinib in 1L EGFR mutated me…
829 viewsJun 24, 2024
YouTubeOncBrothers: Practice-Changing Cancer Discus…
16:45
Amivantamab in combination with lazertinib for osimertinib-relapsed…
1.8K viewsAug 4, 2021
YouTubeecancer
FDA Approval of Subcutaneous Amivantamab Is Significant Step F…
4 months ago
ajmc.com
See more videos
Static thumbnail place holder